Form Approved: OMB No. 0910-0284 Exp. Date: 7/31/2023. See PRA statement on pg. 3. DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration TRANSMITTAL OF PERIODIC REPORTS AND PROMOTIONAL.

How it works
  • Open form

    Open form follow the instructions

  • Easily sign form

    Easily sign the form with your finger

  • Share form

    Send filled & signed form or save

How to fill out the FDA 2301 online

Filling out the FDA 2301 is crucial for submitting periodic reports and promotional materials for new animal drugs. This guide provides a clear, step-by-step approach to ensure accuracy and compliance with the regulations.

Follow the steps to successfully complete the FDA 2301 online.

  1. Press the ‘Get Form’ button to access the online form and open it in your preferred editor.
  2. Enter the NADA or ANADA number in the corresponding field. If the number has fewer than six digits, make sure to add leading zeros to meet the six-digit requirement.
  3. Fill in the 'Name of Applicant' section with the name of the entity or individual submitting the report.
  4. Provide the 'Date Report Submitted' and 'Date Report Due' using the appropriate date format (MM/DD/YYYY).
  5. Enter the 'Drug Trade Name' and the 'Chemical Name' of the new animal drug in the respective fields.
  6. If applicable, check the box for a 'Combined Report' and list the relevant NADA numbers involved. Refer to the instructions for guidance.
  7. Indicate the report period by filling out the 'From' and 'To' fields with the appropriate dates.
  8. Select the 'Type of Report' by checking one of the options (e.g., 6/12/18/24 Month, Follow Up, Annual, Promo/Ad, Other).
  9. Complete Section 10 with the required information regarding adverse drug experiences, clinical data, mailing pieces, and current package labeling, and provide additional details on a separate sheet if necessary.
  10. For promotional material, fill out Section 11 with the date of issuance, type of material, and identification code.
  11. In Section 12, provide the name and title of the responsible official or U.S. agent, and ensure it is typed or printed clearly.
  12. Include the signature of the above official or agent in Section 13.
  13. Fill in the email address and telephone & fax number of the applicant or agent in the respective fields.
  14. Once all sections are completed, ensure to save your changes. You may download, print, or share the form as required.

Complete your FDA 2301 form online today for compliance and timely submission.

Get form

Experience a faster way to fill out and sign forms on the web. Access the most extensive library of templates available.

Related content

FORM FDA 2301

INSTRUCTIONS FOR COMPLETION OF FORM FDA 2301. Copies of this form may be obtained by...

Learn more
21 CFR § 514.80 - Records and reports concerning...

(4) Periodic drug experience report. This report must be accompanied by a completed Form...

Learn more
FDA Submission Tracking Number (STN): SEOO11118

2301 Ravine Way. Glenview, IL 60025. FDA Submission Tracking Number(STN): SEOO11118. Dear...

Learn more
Questions & Answers

Get answers to your most pressing questions about US Legal Forms API.

Contact support

What is a FDA Form 2253?

Form FDA-2253 - Transmittal of Advertisements and Promotional Labeling for Drugs and Biologics for Human Use (check box #13 “Part II/Final)

Use this Form FDA 3542 only if the NDA holder is submitting information on a patent that claims an approved drug or an approved method of using the drug. If the NDA holder is submitting patent information with an original NDA, an amendment, or a supplement prior to approval, you must use Form FDA 3542a.

Look up the drug in Drugs @ FDA. Most FDA-approved human drugs and therapeutic biologic products are listed in Drugs @ FDA, a searchable database. The database allows you to search by drug name, active ingredient, or application (NDA, ANDA, or BLA) number.

Specifically, this annual summary must include the name of the investigational drug, the number of doses supplied, the number of patients treated, the uses for which the drug was made available, and any known serious adverse events. FDA is required to specify the deadline for such reporting submissions.

Form FDA 2252 is required to accompany all annual report submissions regarding new information that might affect the safety, effectiveness, or labeling of a drug or biological product for human use.

Form FDA 2253 is the standard form Life Sciences companies need to fill out to start the regulatory review process for their promotional content. Along with all the promotional content associated with a submission, the form gathers the information the FDA needs to review advertisements and promotions all in one place.

Foreign Drug Establishment. Collection of GDUFA fees is initiated by industry by filling out a GDUFA cover sheet, (FDA Form 3794), for each of the following human generic drug user fees: ANDA and PAS (Note that a cover sheet is not required for all ANDA and PAS amendments)

Get This Form Now!

Use professional pre-built templates to fill in and sign documents online faster. Get access to thousands of forms.

If you believe that this page should be taken down, please follow our DMCA take down process here.

Get FDA 2301